or
Bookmark and Share
Treatment of disease
   
Document Number
US Patent 4818759
Issued Date
April 4, 1989
Link
Inventors
Map
Abstract
A method of treatment of rheumatoid arthritis in humans in need thereof which comprises administering to said human an effective rheumatoid arthritis treatment amount of compound 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine or pharmaceutically acceptable acid addition salt thereof.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
7
Comments:
no comments yet
Owner
Published
April 4, 1989
Application Number
07/152,837
Filed
February 5, 1988
US Classification
514/266.4  
Int'l Classification
A61K   31/505   (20060101)  
Attorney/Law Firm
Priority Data
Feb 06, 1987 [GB] 8702758
USPTO Field of Search
514/260  
Related Patents
5059595 - Pharmaceutical compositions containing 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in controlled-release form active in the therapy of organic mental disturbances - Owned by Bioresearch, S.p.A. (Milan,IT)

This invention relates to pharmaceutical compositions containing 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutical acceptable salts in controlled-release form which are active in the therapy of organic mental disturbances and in particular in the treatment of senile and presenile primary degenerative dementia of Alzheimer type and multiinfarctual dementia.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us